SUBSCRIBE
SUBSCRIBE

Juno Therapeutics

NEWS
Juno Therapeutics was acquired by Bristol-Myers Squibb in 2019.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Juno, Five Prime are Quiet Winners at AACR
April 21, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Juno Goes Global With Launch of New China-Based JW Biotechnology (Shanghai) Co.
April 8, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Booming Juno May Leave Washington if Policy Makers Continue to Ignore Biotech Incentives
April 4, 2016
 · 
3 min read
Business
Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno
March 3, 2016
 · 
3 min read
Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle
Job Trends
Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle
February 17, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Juno Awards CEO and CFO Special Bonuses After Inking $1 Billion Celgene Deal
February 8, 2016
 · 
3 min read
Business
Another Amgen Exec Lands Gig at Fast-Growing Juno
November 3, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Onco-Immunology Companies like Juno, Novartis AG, Kite Pharma Struggle to Mass Produce Custom Cancer Therapies
October 30, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
BioForest
In the Hot CAR-T Market, Analyst Projects Juno Stock to Double
August 20, 2015
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2015
JOBS
IN THE PRESS
Business
Juno Announces Early HSR Clearance For Global Collaboration With Celgene
August 5, 2015
 · 
4 min read
BioForest
FDA OKs Juno’s IND for Lead Leukemia Candidate JCAR015
July 31, 2015
 · 
5 min read
BioForest
Juno Therapeutics Announces FDA Acceptance Of Investigational New Drug Application For JCAR017 In Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
June 29, 2015
 · 
5 min read
Business
Space Still Available in Juno Therapeutics’s New Seattle Building
June 18, 2015
 · 
1 min read
BioForest
Juno Therapeutics To Present At The Goldman, Sachs & Co. 36th Annual Global Healthcare Conference
June 3, 2015
 · 
3 min read
Drug Development
ASCO15: Juno Therapeutics’s Investigational CAR T Cell Product Candidate JCAR015 Demonstrates Encouraging Clinical Responses In Patients With B-Cell Cancers
June 1, 2015
 · 
4 min read
Drug Development
ASCO15: Juno Therapeutics’s Investigational CAR T Cell Product Candidate JCAR014 Demonstrates Encouraging Clinical Responses And Translational Insights In Patients With B-Cell Cancers
June 1, 2015
 · 
5 min read
Business
Juno Therapeutics Taps Ex-Roche Exec to Head R&D
May 29, 2015
 · 
5 min read
Biotech Bay
Fluidigm Corporation Brings Automated Targeted Library Prep To Juno Therapeutics
May 27, 2015
 · 
6 min read
Business
Juno Therapeutics Reports First Quarter 2015 Financial Results
May 11, 2015
 · 
14 min read
Load More